dc.contributor.author |
Caimacan, Adriana |
|
dc.contributor.author |
Don, Roman |
|
dc.date.accessioned |
2021-10-06T08:25:04Z |
|
dc.date.available |
2021-10-06T08:25:04Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
CAIMACAN, Adriana, DON, Roman. The role of the 3 generations of antihistamines in treating allergies. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 9. |
en_US |
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/18092 |
|
dc.description |
Department of Pharmacology and Clinical Pharmacology, State University of Medicine and Pharmacy “Nicolae Testemitanu”,
Chisinau, Republic of Moldova |
|
dc.description.abstract |
Introduction: Recent statistical data show a constantly increasing incidence of allergic
disorders emphasizing the role of the development of new anti-allergic medication in the treatment
of different allergies. HI-antihistamines (H1A) represent the class of anti-allergies most used by
physicians in handling the immediate-type of hypersensitivity reactions. Currently, there are 3
generations of HI-antihistamines, classified according to their selectivity and sedative properties.
Purpose and Objectives: The study was designed to find the prevalence of HI-antihistamines
among other administered anti-allergic drugs and to determine the particularities of their use.
Materials and Methods: We collected data from 53 medical records inscribed in the
department of Allergology from Republican Clinical Hospital of Republic of Moldova, in
November - December, 2013.There were patients diagnosed with various immediate-type allergic
reactions, such as : Quincke’s edema, allergic dermatitis, acute and chronic urticaria, drug allergy
and Stevens-Johnson syndrome. The information about the antihistamine drugs prescribed, length
and route of administration in stationary versus further ambulatory periods was analyzed.
Results: We found that 28 patients out of 53 (52,83%) were prescribed antihistamines
stationary and 20 out of 53(37,73%) - ambulatory. The drugs used stationary were: chloropyramine
and promethazine - both first (classical) generation HI A, administered in all patients(100%),
intravenous, for an average of 7-8 days. The drugs used ambulatory were as following : clemastine (first generation HI A) - in 1 patient (1,88 %), intravenous for 5 days; bilastine (second generation
HI A) - in 8 patients (15,1 %), orally for 1 month; levocetirizine and desloratadine (third generation
HI A) - in 11 patients (20,75 %), orally for 1-2 months.
Conclusion: The role of classical HI-antihistamines in clinical practice remains still high. Second
and third generations of HI A are more preferred in further ambulatory anti-allergic treatment, partly due
to the absence of the sedative effect of the classical HI A, important for people who need increased
attention in practicing their professions, and partly due to their prolonged time of action. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
en_US |
dc.relation.ispartof |
MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
en_US |
dc.subject |
allergic disorders |
en_US |
dc.subject |
anti-allergic medication |
en_US |
dc.subject |
third generation HI-antihistamines |
en_US |
dc.title |
The role of the 3 generations of antihistamines in treating allergies |
en_US |
dc.type |
Other |
en_US |